Clinical Trial Update: Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating alkaline phosphatase to prevent systemic inflammation after cardiopulmonary bypass during cardiac surgery is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Inflammation

Drugs mentioned

• Alkaline Phosphatase (alkaline phosphatase)

Snippet

Sponsor: Alloksys Life Sciences B.V. | Conditions: Systemic Inflammation, Cardiopulmonary-bypass | Phase 2, Phase 3 | Status: RECRUITING